lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
2011 ◽
Vol 40
(8)
◽
pp. 621-628
◽
2020 ◽